PEYAX | VIVIX | PEYAX / VIVIX | |
Total Expense Ratio | 0.88 | 0.04 | 2,200% |
Annual Report Gross Expense Ratio | 0.88 | 0.04 | 2,200% |
Fund Existence | 48 years | 27 years | - |
Gain YTD | -7.380 | -7.289 | 101% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 33.1B | 195B | 17% |
Annual Yield % from dividends | 1.11 | 2.27 | 49% |
Returns for 1 year | -5.43 | -1.55 | 351% |
Returns for 3 years | 6.33 | 6.83 | 93% |
Returns for 5 years | 78.84 | 82.54 | 96% |
Returns for 10 years | 65.47 | 87.57 | 75% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
UJUL | 31.69 | -0.97 | -2.97% |
Innovator U.S. Equity Ultra BffrETF™-Jul | |||
EQWL | 93.35 | -5.88 | -5.93% |
Invesco S&P 100 Equal Weight ETF | |||
SPXX | 15.51 | -1.08 | -6.51% |
Nuveen S&P 500 Dynamic Overwrite Fund | |||
VGK | 65.02 | -4.59 | -6.59% |
Vanguard FTSE Europe ETF | |||
UCIB | 25.16 | -2.08 | -7.64% |
UBS ETRACS BgCstMtCdy(CMCI)TtlRetETNSerB |